01 3Mounjaro
02 2Zepbound
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 483
2021 Revenue in Millions : 0
Growth (%) : New Launch in 2022
Main Therapeutic Indication : Nutritional Deficiency
Currency : USD
2023 Revenue in Millions : 176
2022 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 5,163
2022 Revenue in Millions : 483
Growth (%) : 970
Main Therapeutic Indication : Nutritional Deficiency
Currency : USD
2024 Revenue in Millions : 4,926
2023 Revenue in Millions : 176
Growth (%) : 2,702
Main Therapeutic Indication : Diabetes
Currency : USD
2024 Revenue in Millions : 11,540
2023 Revenue in Millions : 5,163
Growth (%) : 124
